FIELD: medicine.
SUBSTANCE: to simulate the hypoxic damage of eye and retina surface tissues, which leads to apoptosis activation, the experimental animal is exposed to the physical factor. Histological eye tissue samples are obtained and cells being in the apoptosis state are identified therein. The animal is placed into a sealed 0.10-0.15 m3 chamber, where nitrogen gas is delivered at a rate of 2.0-2.4 liter/min, until seizures begin in the experimental animal.
EFFECT: possibility of selective activation of apoptotic processes simultaneously in the eye and retina tissues to assess hypoxia among the factors that cause dry eye syndrome and retinopathy.
6 dwg
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR PREVENTING PROGRESSION OF APOPTOTIC AND ARRESTING NECROTIC ALTERATIONS IN BODY TISSUE | 2005 |
|
RU2311180C2 |
WAY TO CREATE TRANSIENT RETINAL ISCHEMIA | 2015 |
|
RU2577242C1 |
METHOD OF SIMULATING TRANSIENT RETINAL ISCHEMIA IN RATS | 2015 |
|
RU2577449C1 |
METHOD FOR DRY EYE SYNDROME TREATMENT IN PATIENTS WITH DIABETES MELLITUS | 2020 |
|
RU2749984C1 |
APPLICATION OF (2-IMIDAZOLIN-2-YLAMINO) QUINOXALINES IN DEMENTIA AND PARKINSON'S DISEASE TREATMENT | 2003 |
|
RU2332218C2 |
TREATMENT OF EYE DISEASES SUCH AS MACULAR DEGENERATION, GLAUCOMA AND DIABETIC RETINOPATHY WITH MEDICATIONS THAT ELIMINATE AGING CELLS | 2018 |
|
RU2815482C2 |
METHOD OF INCREMENT IN RETINA CAPACITY WITH VARIOUS PATHOLOGIES | 2008 |
|
RU2364382C1 |
CDP-CHOLINE - PROPHYLACTIC AGENT FOR TREATMENT OF CEREBRAL ISCHEMIA AND METHOD FOR TREATMENT WITH ITS USING | 2001 |
|
RU2255741C2 |
PHARMACEUTICAL PREPARATION CONTAINING SUPERNATANT OF BLOOD MONONUCLEAR CELL CULTURE | 2009 |
|
RU2533253C2 |
AGENT WITH ANTIAPOPTOTIC ACTIVITY | 2018 |
|
RU2685428C1 |
Authors
Dates
2017-03-30—Published
2016-04-12—Filed